This compound may thus provide an alternative treatment for phosphodiesterase 5 (PDE5) inhibitors, which are usually employed in ED therapy, considering that half of the patients with diabetes do not respond to PDE5 inhibitors. Here, PDE5A is linked to diabetes mellitus.